Signed-off-by: Christophe de Dinechin
FirstFT: the day's biggest stories。heLLoword翻译官方下载对此有专业解读
当然，风险亦不容忽视。Infigratinib是泛FGFR1-4抑制剂，对FGFR1等的抑制可能引起高磷血症等副作用。3期试验中约有4%患者出现轻度、短暂的高磷血症。在儿科长期用药的背景下，其安全性仍需更严格的监测，监管的要求也会更严格。，更多细节参见旺商聊官方下载
New methods such as mini 3D ‘organoids’ are slowly phasing out animal testing in some areas of research. Plus, how to spot a fraudulent paper and the surprising science of squeaky sneakers.